ResMed Continues To Build Digital-Medicine Business With $225M Acquisition Of Propeller Health
Executive Summary
Propeller Health bills itself as a digital respiratory therapeutics company, providing a mobile platform that communicates with sensors on patients' inhaler devices to help them manage chronic obstructive pulmonary disease and asthma. This the second major acquisition ResMed has announced in the last month.
You may also be interested in...
ResMed Beats Q2 Revenue Estimates, Exits Portable Oxygen Business
ResMed beat Wall Street analysts’ projections for sales growth for the second quarter of 2021, announced exit of its portable oxygen market.
ResMed Ready To Supply Digital Answers To Health Care’s Demand Challenges
ResMed’s respiratory device portfolio has put it front and center of the global medtech industry’s efforts to bring COVID-19 under control. UK and Ireland country manager Antoine Valterio tells In Vivo how the company rose to the challenge, and how providers are now seeing digital technologies in a new light.
ResMed Ready To Supply The Digital Answers To Health Care’s Demand Challenges
ResMed’s respiratory device portfolio has put the company front and center of the global medtech industry’s efforts to bring COVID-19 under control. UK and Ireland country manager Antoine Valterio tells Medtech Insight how the company rose to the challenge, and how providers are now seeing digital technologies in a new light.